Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03848754
Title Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Medical College of Wisconsin
Indications

acute myeloid leukemia

Therapies

Gemtuzumab ozogamicin + Pracinostat

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Froedtert Hospital & the Medical College of Wisconsin Recruiting Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field